Johnson & Johnson ends partnership with Bavarian Nordic on hepatitis B and HPV vaccines
- The Rise of Immunocell Therapy and the Era of “Farewell to Chemotherapy”
- Second Death Linked to Red Yeast Rice Supplement Reported in Japan
- Why Was Dementia Almost Nonexistent in Ancient Greece and Rome?
- Common Household Chemicals Pose Potential Threat to Brain Health
- Alarming Levels of Lead Detected in Chicago Tap Water
- Ribociclib Plus Endocrine Therapy Shows Promise in Early Breast Cancer
Johnson & Johnson ends partnership with Bavarian Nordic on hepatitis B and HPV vaccines
- Long COVID Brain Fog: Blood-Brain Barrier Damage and Persistent Inflammation
- Japan: Over 10,000 Applications for Health Damage from COVID-19 Vaccines
- FDA has mandated a top-level black box warning for all marketed CAR-T therapies
- ‘Elixir of Immortality’ Nicotinamide Riboside (NR) Virtually No Effect
- Can people with high blood pressure eat peanuts?
- What is the difference between dopamine and dobutamine?
- How long can the patient live after heart stent surgery?
Johnson & Johnson ends partnership with Bavarian Nordic on hepatitis B and HPV vaccines
On May 9, Johnson & Johnson announced that it had terminated its partnership and licensing agreement with Bavarian Nordic.
The main content of the agreement is to use Bavarian Nordic’s MVA-BN technology to develop potential vaccines against hepatitis B virus and human papilloma virus. Currently, J&J has not used the technology to develop a hepatitis B vaccine.
For hepatitis B, Johnson & Johnson will continue to prioritize the use of its technology platform to develop related therapeutic drugs. Because hepatitis B remains a serious health problem, about 296 million people worldwide are affected by the disease, and nearly 900,000 people die from it every year.
For human papillomavirus, J&J does not intend to focus its research on its therapeutic vaccine because a preventive vaccine is already widely used.
However, J&J’s collaboration with the company on HIV and Ebola is still ongoing.
(source:internet, reference only)
Disclaimer of medicaltrend.org
Important Note: The information provided is for informational purposes only and should not be considered as medical advice.